NEWS

PRESS RELEASES

05.18.16
Xencor Reports Complete Data Results from XmAb7195 Phase 1a Trial Showing Rapid Reduction of Serum IgE in High IgE Atopic Subjects at ATS 2016 International Conference

ARTICLES

10 Next-Gen Biologics Platforms: – FierceBiotech

EVENTS

Xencor 2016 Annual Stockholders Meeting: June 23, 2016 1:30 PM PST

The offices of Cooley LLP — 4401 Eastgate Mall, San Diego, CA 92121